Haleon is a consumer-healthcare company spun out of GSK, behind Sensodyne, Advil, Centrum and Panadol. It trades on London Stock Exchange under the ticker HLN, in the Consumer Health sector.
Key Facts
| Item | Details |
|---|---|
| Ticker | HLN |
| Exchange | London Stock Exchange (HLN) |
| Sector | Consumer Health |
| Headquarters | Weybridge, UK |
Bull Case & Risks
Bull Case
- Leading consumer-health brands
- Defensive, pricing-led growth
- Deleveraging and margin upside
Risks
- Litigation/legacy overhang
- Slow category growth
Outlook
Haleon is a pure-play consumer-health business with strong brands, deleveraging toward steadier compounding.
Educational information only, not investment advice. Stocks carry risk including possible loss of principal; past performance does not guarantee future results.